Prostate News Archive
21-Jan-2007
Leukemia halts study of prostate cancer drug (Newsday)
A cancer research consortium has halted a major study involving men with aggressive prostate cancer because the drug under study caused leukemia in three of 488 patients who received it. Dendreon Shares Rise on Good News for Prostate Cancer Drug (SeekingAlpha via Yahoo! Finance)
Centient Biotech Investor submits: On Tuesday, January 16, Dendreon announced the FDA has accepted its BLA for Provenge , and granted it priority review status. Provenge is an investigational active cellular immunotherapy [ACI ] for the treatment of asymptomatic, androgen-independent, or hormone-refractory prostate cancer [AIPC ]. Sunshine Pill For Prostate Cancer In 2009 (Science Daily)
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the ... Scientists Explore Virus-Prostate Cancer Link (HealthCentral.com)
TUESDAY, Jan. 16 (HealthDay News) -- Scientists are unraveling the secrets of a virus found in prostate cancer patients that might spur the disease. In a new study, a U.S. team of researchers says the virus appears to be an infectious retrovirus with the ability to hijack body cells. Vitamin pill for prostate cancer (BBC News)
Scientists develop a vitamin D pill in efforts to extend the life of patients with advanced prostate cancer.
Back to Prostate News Archive
